Citi Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. NVDA
2. SPCX
3. KOD
4. USO
5. META
6. MU
7. MIRM
8. MDB
9. LLY
10. SPY

October 22, 2018 5:20 AM EDT
Get Alerts BMY Hot Sheet
Price: $63.24 +0.60%

Rating Summary:
    12 Buy, 22 Hold, 4 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 11 | New: 45
Join SI Premium – FREE

Citi analyst Andrew Baum downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral with a price target of $57.00 (from $62.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $53.18 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades

Related Entities

Citi